SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-22-003341
Filing Date
2022-09-07
Accepted
2022-09-07 07:28:27
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk2228395.htm   iXBRL 6-K 20380
2 EXHIBIT 99.1 exhibit_99-1.htm   iXBRL EX-99.1 1112930
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 49628
  Complete submission text file 0001178913-22-003341.txt   5154920

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE evgn-20220630.xsd EX-101.SCH 61103
5 XBRL CALCULATION FILE evgn-20220630_cal.xml EX-101.CAL 45372
6 XBRL DEFINITION FILE evgn-20220630_def.xml EX-101.DEF 92857
7 XBRL LABEL FILE evgn-20220630_lab.xml EX-101.LAB 441452
8 XBRL PRESENTATION FILE evgn-20220630_pre.xml EX-101.PRE 208486
43 EXTRACTED XBRL INSTANCE DOCUMENT zk2228395_htm.xml XML 1111515
Mailing Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121
Business Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121 97289311900
Evogene Ltd. (Filer) CIK: 0001574565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36187 | Film No.: 221229927
SIC: 2870 Agricultural Chemicals